These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 20412035)

  • 1. Clinical management of hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):10S-5S. PubMed ID: 20412035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment guidelines for hepatic encephalopathy.
    Thompson JR
    Pharmacotherapy; 2010 May; 30(5 Pt 2):4S-9S. PubMed ID: 20412034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
    Montagnese S; Gordon HM; Jackson C; Smith J; Tognella P; Jethwa N; Sherratt RM; Morgan MY
    Hepatology; 2005 Oct; 42(4):772-81. PubMed ID: 16175619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal hepatic encephalopathy.
    Sharma P
    J Assoc Physicians India; 2009 Nov; 57():760-3. PubMed ID: 20329443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
    Jindal A; Sharma BC; Sachdeva S; Chawla R; Srivastava S; Maharshi S
    Dig Liver Dis; 2015 Sep; 47(9):769-74. PubMed ID: 26022229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the intestinal lavage with a solution of mannitol effective in the prevention of post-hemorrhagic hepatic encephalopathy in patients with liver cirrhosis? Results of a randomized prospective study].
    Rolachon A; Zarski JP; Lutz JM; Fournet J; Hostein J
    Gastroenterol Clin Biol; 1994; 18(12):1057-62. PubMed ID: 7750677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
    Moriwaki H; Shiraki M; Iwasa J; Terakura Y
    J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.